HomeCompareYPHDF vs EQR

YPHDF vs EQR: Dividend Comparison 2026

YPHDF yields 0.38% · EQR yields 4.73%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 YPHDF wins by $293.8K in total portfolio value· pulled ahead in Year 7
10 years
YPHDF
YPHDF
● Live price
0.38%
Share price
$367.90
Annual div
$1.39
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$334.3K
Annual income
$221,423.15
Full YPHDF calculator →
EQR
EQR
● Live price
4.73%
Share price
$58.58
Annual div
$2.77
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$40.5K
Annual income
$3,819.61
Full EQR calculator →

Portfolio growth — YPHDF vs EQR

📍 YPHDF pulled ahead of the other in Year 7

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodYPHDFEQR
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, YPHDF + EQR cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
YPHDF pays
EQR pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

YPHDF
Annual income on $10K today (after 15% tax)
$32.04/yr
After 10yr DRIP, annual income (after tax)
$188,209.68/yr
EQR
Annual income on $10K today (after 15% tax)
$401.93/yr
After 10yr DRIP, annual income (after tax)
$3,246.67/yr
At 15% tax rate, YPHDF beats the other by $184,963.01/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of YPHDF + EQR for your $10,000?

YPHDF: 50%EQR: 50%
100% EQR50/50100% YPHDF
Portfolio after 10yr
$187.4K
Annual income
$112,621.38/yr
Blended yield
60.11%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EQR right now

YPHDF
Analyst Ratings
1
Buy
2
Hold
Consensus: Hold
Altman Z
8.5
Piotroski
7/9
EQR
Analyst Ratings
16
Buy
28
Hold
2
Sell
Consensus: Hold
Price Target
$70.35
+20.1% upside vs current
Range: $63.00 — $78.50
Altman Z
1.8
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

YPHDF buys
0
EQR buys
0
No recent congressional trades found for YPHDF or EQR in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricYPHDFEQR
Forward yield0.38%4.73%
Annual dividend / share$1.39$2.77
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%15.8%
Portfolio after 10y$334.3K$40.5K
Annual income after 10y$221,423.15$3,819.61
Total dividends collected$304.7K$16.9K
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusHoldHold

Year-by-year: YPHDF vs EQR ($10,000, DRIP)

YearYPHDF PortfolioYPHDF Income/yrEQR PortfolioEQR Income/yrGap
1$10,775$75.38$11,248$547.57$473.00EQR
2$11,681$151.82$12,701$666.53$1.0KEQR
3$12,807$307.64$14,405$814.59$1.6KEQR
4$14,334$630.42$16,413$999.84$2.1KEQR
5$16,656$1,318.85$18,795$1,232.92$2.1KEQR
6$20,686$2,864.52$21,639$1,527.95$953.00EQR
7← crossover$28,784$6,649.86$25,057$1,903.80+$3.7KYPHDF
8$48,095$17,295.38$29,197$2,385.87+$18.9KYPHDF
9$105,476$54,015.32$34,250$3,008.70+$71.2KYPHDF
10$334,283$221,423.15$40,467$3,819.61+$293.8KYPHDF

YPHDF vs EQR: Complete Analysis 2026

YPHDFStock

Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for pharmaceutical and biotechnology companies. The company operates in two segments, Ypsomed Delivery Systems and Ypsomed Diabetes Care. The Ypsomed Delivery Systems segment provides various injection systems, such as pen injectors, auto injectors, patch injectors, and wearable injectors, as well as other smart devices. This segment offers its products under the YDS brand. The Ypsomed Diabetes Care segment sells and trades in insulin pumps, infusion sets, pen needles, blood glucose monitoring systems, accessories, and other day-to-day items for diabetics. This segment offers its products under the mylife brand name. The company offers precision turned parts; and contract manufacturing and other services. It markets its products through biotechnology and pharmaceutical partners, as well as through its own distribution network and independent distributors. It operates in Switzerland, Europe, North America, and internationally. Ypsomed Holding AG was founded in 1984 and is headquartered in Burgdorf, Switzerland.

Full YPHDF Calculator →

EQRREIT

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, D.C., Seattle, San Francisco, Southern California and Denver.

Full EQR Calculator →
📬

Get this YPHDF vs EQR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

YPHDF vs SCHDYPHDF vs JEPIYPHDF vs OYPHDF vs KOYPHDF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.